Amgen Europe
also invests · investor profileThousand Oaks, US · Founded 1980 · 39,178 employees on LinkedIn · 4 known investors
Amgen develops therapies based on biotechnology and scientific research aimed at treating patients and improving or saving lives. It operates in the biopharmaceutical industry, moving discoveries from the laboratory through clinical development to market.
Founders & leadership
Amgen Europe was founded in 1980 by William K. Bowes and George B. Rathmann.
WK
William K. BowesFounder
GB
George B. RathmannFirst CEO
Investors · 4
Founder mafia
The Amgen mafia →10 people who came through Amgen went on to found or lead other companies.
Parker ConradProduct ManagerFounded Zenefits +1Seth LieblichBusiness DevelopmentFounded Protomer +1James LiVice President and General Manager, Greater ChinaFounded JW TherapeuticsMilad AlucozaiExternal AdvisorFounded Revalia Bio, Inc.Milad RiazifarIntern - Therapeutic DiscoveryFounded Entelexo BiotherapeuticsKal Patel, M.D., MBAGlobal Marketing Lead - EnbrelFounded BrightinsightMichael C. Bassik, Ph.D.Scientific Advisory BoardFounded Stylus MedicineChris SevernSummer Intern, Global Health EconomicsFounded Turquoise HealthDenny LanfearFounder and Vice President, Process Development DepartmentFounded Coherus BiosciencesXueming QianPrincipal ScientistFounded Transcenta Holding
Frequently asked questions
- What does Amgen Europe do?
- Amgen develops therapies based on biotechnology and scientific research aimed at treating patients and improving or saving lives. It operates in the biopharmaceutical industry, moving discoveries from the laboratory through clinical development to market.
- Who founded Amgen Europe?
- Amgen Europe was founded by William K. Bowes, George B. Rathmann in 1980.
- Who are Amgen Europe's investors?
- Amgen Europe's investors include Asset Management Company, BOM, Boulder Ventures, Mayfield Fund.
- Where is Amgen Europe headquartered?
- Amgen Europe is headquartered in Thousand Oaks, US.